You are here

Ido Amit

Combat team: A dendritic cell (right) and a T cell, both from a mouse with skin cancer, combined using the BiCE antibody (yellow)

A new kind of immunotherapy, based on crosstalk between different immune cells, could pave the way for innovative treatments of cancer and...

Decades-Old Mystery of Red Blood Cell Production Finally Solved

Identifying the cells producing the hormone EPO may lead to the development of new therapies for treating anemia resulting from kidney disease and...

(l-r) Profs. Chamutal Gur and Ido Amit

Weizmann Institute of Science researchers, in collaboration with Hadassah and Rambam physicians, present a new roadmap for exploring poorly...

multiple myeloma drug resistant cells

From bedside to bench and back: Researchers reveal a genetic signature that could help overcome drug resistance in some of the most aggressive...

Sharing Science

A postdoc talks about complicated research, living at the Institute and the joys of scientific outreach

Surprising Players in Acute Liver Failure Point to Potential Treatment

Gut microbes and host cells jointly contribute to the progression of this mostly incurable disease

pregnant belly with mask on

In a study in mice, the mother’s natural anti-viral proteins disrupted the development of neural circuits in the fetus

Tissue sample from triple-negative breast cancer, stained for the presence of cancer cells (red) and the two types of cancer-associated fibroblasts: pCAFs (magenta) and sCAFs (green). The nuclei of all cells are stained blue

Supporting actors in cancer growth may help predict the course of the disease

Prof. Ido Amit

Prof. Ido Amit is the recipient of the Michael Bruno Memorial Award from the Israel Institute for Advanced Studies at the Hebrew University of...

Prof. Ido Amit

Prof. Ido Amit is the recipient of the Sanofi – Institut Pasteur 2019 Junior Award